Do GLP-1s prevent heart attacks?

Yes — clinical trials show significant reduction in heart attacks and cardiovascular death, particularly in patients with existing cardiovascular disease.

Which GLP-1 is best for heart disease?

Wegovy has FDA approval for cardiovascular risk reduction. Other GLP-1s also show cardiovascular benefits. Discuss with your cardiologist.

Can GLP-1s replace statins?

No — GLP-1s and statins work differently. Most heart patients need both. Don't stop statins without discussing with cardiologist.

GLP-1 and Heart Disease: Cardiovascular Benefits Explained

GLP-1 medications have proven cardiovascular benefits beyond weight loss. This guide covers what we know about GLP-1s and heart disease.

Cardiovascular benefits of GLP-1s

Clinical trials show GLP-1 medications provide significant cardiovascular benefits:

Reduced heart attacks — 12-16% reduction in major adverse cardiovascular events
Reduced strokes — significant reduction in stroke risk
Reduced cardiovascular death — 12-20% reduction
Improved blood pressure — modest reduction
Improved cholesterol — reduced LDL and triglycerides
Reduced inflammation — lower CRP levels

Wegovy has FDA approval specifically for cardiovascular risk reduction in adults with obesity and established cardiovascular disease.

Why GLP-1s help the heart

GLP-1s improve cardiovascular health through multiple mechanisms:

Weight loss — reduces strain on heart
Improved insulin sensitivity — reduces metabolic stress
Reduced inflammation — key driver of heart disease
Improved endothelial function — better blood vessel health
Reduced blood pressure — modest but meaningful
Improved lipid profile — better cholesterol
Direct cardiac effects — GLP-1 receptors on heart

Who benefits most

Strongest evidence for:

Patients with type 2 diabetes and cardiovascular disease
Patients with obesity and established cardiovascular disease
Patients with high cardiovascular risk factors

Benefits apply to:

Patients with diabetes without cardiovascular disease (preventive)
Patients with obesity without cardiovascular disease (preventive)
Most adults with metabolic risk factors

Considerations for heart patients

Work with cardiologist

If you have heart disease, your cardiologist should be involved in GLP-1 treatment decisions. They can advise on:

Medication interactions
Appropriate GLP-1 choice
Monitoring needs
Adjustments to other cardiac medications

Medication adjustments

As GLP-1s improve cardiovascular health, other medications may need adjustment:

Blood pressure medications (may need lower dose)
Diabetes medications (insulin, sulfonylureas may need reduction)
Statins (may need dose adjustment)

Watch for

Low blood sugar (if also on insulin/sulfonylureas)
Low blood pressure (especially when standing)
Dehydration (affects heart)
Heart rate changes (GLP-1s may slightly increase heart rate)